These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19201411)

  • 21. Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation.
    Aguilar-Salinas CA; Díaz-Polanco A; Quintana E; Macias N; Arellano A; Ramírez E; Ordóñez ML; Velásquez-Alva C; Gómez Pérez FJ; Alberú J; Correa-Rotter R
    Am J Kidney Dis; 2002 Jul; 40(1):169-77. PubMed ID: 12087575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
    Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
    Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
    Cortner JA; Coates PM; Liacouras CA; Jarvik GP
    J Pediatr; 1993 Aug; 123(2):177-84. PubMed ID: 8345411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
    Haffner SM; Kushwaha RS; Hazzard WR
    Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of small, dense LDL cholesterol in patients with hyperlipidemia and type 2 diabetes].
    Shishino K; Ochi M; Murase M; Osawa H; Makino H
    Rinsho Byori; 2007 Aug; 55(8):705-11. PubMed ID: 17882792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDL physical and chemical properties in familial combined hyperlipidemia.
    Hokanson JE; Krauss RM; Albers JJ; Austin MA; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):452-9. PubMed ID: 7749856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia.
    Hokanson JE; Austin MA; Zambon A; Brunzell JD
    Arterioscler Thromb; 1993 Mar; 13(3):427-34. PubMed ID: 8443147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased arterial stiffness in familial combined hyperlipidemia.
    Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
    J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
    Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
    J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age).
    Wiesbauer F; Blessberger H; Azar D; Goliasch G; Wagner O; Gerhold L; Huber K; Widhalm K; Abdolvahab F; Sodeck G; Maurer G; Schillinger M
    Eur Heart J; 2009 May; 30(9):1073-9. PubMed ID: 19276196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.
    Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.
    Yamazaki K; Bujo H; Taira K; Itou N; Shibasaki M; Takahashi K; Saito Y
    Atherosclerosis; 2004 Jan; 172(1):181-7. PubMed ID: 14709374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutrition, body weight and deterioration of familial combined hyperlipidemia.
    Koprovicová J; Kollár J; Petrásová D
    Coll Antropol; 2006 Dec; 30(4):777-82. PubMed ID: 17243549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.
    Jarvik GP; Brunzell JD; Austin MA; Krauss RM; Motulsky AG; Wijsman E
    Arterioscler Thromb; 1994 Nov; 14(11):1687-94. PubMed ID: 7947591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia.
    De Michele M; Iannuzzi A; Salvato A; Pauciullo P; Gentile M; Iannuzzo G; Panico S; Pujia A; Bond GM; Rubba P
    Heart; 2007 Jan; 93(1):78-81. PubMed ID: 16807271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study.
    McNeely MJ; Edwards KL; Marcovina SM; Brunzell JD; Motulsky AG; Austin MA
    Atherosclerosis; 2001 Dec; 159(2):471-81. PubMed ID: 11730829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
    Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
    Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.